2-(2-aminopropan-2-yl)-N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide manufacturer CAS:518048-03-8
Sep 9th, 2022 at 08:33 Biological and Pharmaceutical Chemicals Hull 48 views Reference: joQeZ632epZ
Location: Hull
Price: Contact us
Product Name:
2-(2-aminopropan-2-yl)-N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide
Synonym: Intermediatesof Raltegravir; 6-dihydropyrimidine-4-carboxamide;
2-(1-amino-1-methyl-ethyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydro-pyrimidine-4-carboxylic acid 4-fluoro-benzylamide
Cas No.: 518048-03-8
Formula: C16H19FN4O3
MW: 334.35
EINECSNo.: 1592732-453-0
HS Code: 2933599090
UN No.: N.A
Hazard class: Non-dangerous goods
Specification
| Items of Analysis | Standard of Analysis | Test Results |
| Appearance | Whiteor similar white powder | Conforms |
| Purity(HPLC) | ≥99% | 99.75% |
| Single Impurity | ≤1.0% | 0.07% |
| Total impurities | ≤1.0% | 0.25% |
| Loss on drying | ≤0.5% | 0.12% |
| Residue on Ignition | ≤0.15% | 0.13% |
| Conclusion | Conforms to Factory Standard | |
Application
An important intermediates for the synthesis of AIDS antiviral drug Raltegravir.
Packaging
25 kg/barrel, can also be packaged according to customer requirements.
Storage
Store in a cool, ventilated warehouse.
Keep away from fire and heat.
The temperature should not exceed 37 °C.
Please visit our website if you have any inquiry: 2-(2-aminopropan-2-yl)-N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide.If you can't find materials from around the world, please let us know and we will research and produce them in our labs equipped with high technology.
Inno Pharmchem (Pharmaceutical Intermediates Manufacturers in China) is exclusively focusing on the manufacturing of API's Intermediates, such as 2-(2-aminopropan-2-yl)-N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide, cas:518048-03-8 , 2-(2-aminopropan-2-yl)-N-(4-fluorophenyl)methyl-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide and so on. We have helped clients businesses by scaling up its pharmaceutical products through the development of innovative processes and optimizing the production process thus it making it cost-efficient.
Keywords: 2-(2-aminopropan-2-yl)-N-(4-fluorophenyl)methyl-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide manufacturer;2-(1-amino-1-methyl-ethyl)-5-hydroxy-1-methyl-6-oxo-16-dihydro-pyrimidine-4-carboxylic acid 4-fluoro-benzylamide factory;6-dihydropyrimidine-4-carboxamide producer;Intermediate of Raltegravir vendor;2-(2-aminopropan-2-yl)-N-(4-fluorophenyl)methyl-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide supplier;518048-03-8 manufacturer.
